Experience with Carrier Screening and Prenatal Diagnosis for Sixteen Ashkenazi Jewish Genetic Diseases

類似資料

• Carrier Screening for Mucolipidosis Type IV in the American Ashkenazi Jewish Population
  著者:: Edelmann, Lisa, 等
  出版事項: (2002)
• Warfarin Pharmacogenetics: CYP2C9 and VKORC1 Genotypes Predict Different Sensitivity and Resistance Frequencies in the Ashkenazi and Sephardi Jewish Populations
  著者:: Scott, Stuart A., 等
  出版事項: (2008)
• Type 1 Gaucher Disease: Significant disease manifestations in “asymptomatic” homozygotes identified by prenatal carrier screening
  著者:: Balwani, Manisha, 等
  出版事項: (2010)
• Carrier screening in individuals of Ashkenazi Jewish descent
  著者:: Gross, Susan J., 等
  出版事項: (2008)
• Maple Syrup Urine Disease: Identification and Carrier-Frequency Determination of a Novel Founder Mutation in the Ashkenazi Jewish Population
  著者:: Edelmann, Lisa, 等
  出版事項: (2001)